Biologics World China 2012

3rd ANNUAL Biologics World China continues to provide an industry-focused platform in China, bringing together decision makers across C level management, R&D and Manufacturing in the realms of Biologic drugs, Biosimilars, Vaccines and Blood/Plasma products!

Over 300 industry experts will gather to share best practices and exchange perspectives on raising benchmark of quality, stimulating innovation and increasing global competitiveness. Regulatory guidelines, parameters for biosimilars, case studies on cell lines and process development, scale-up and downstream methodologies, single-use technology and a showcase of novel biologics and vaccines will be featured in the 2012 show.

It will be a one-stop solution for you to reach out to China's burgeoning biologics market!

This year topics include:

• Regulatory guidelines and pathways for biosimilars in China
• Pricing mechanism and distribution strategies of biosimilars in China
• Best practices in process development and engineering for mAbs and vaccines
• Scale-up for downstream processing
• Innovative cell lines for mAb and vaccine development
• Case studies on novel or next generation biologics
• WHO pre-qualification for Chinese vaccines and biologics
• IP management of biologic products in China
• Implementing quality control throughout entire bioprocess
• Optimizing upstream and downstream processes
• Partnership models and successful case studies with Chinese biologic companies
• Analytical methods to prove biosimilarity

• Keynote Speakers
Dr Joe Zhou,Dr Ke Wu,Dr Michael Yu,Dr Klaus Kaiser,Dr Allan Riting Liu,Robert Chen,Dr Saul Mashaal,Zoe Wang and many more.